Stonegate Investment Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $715K | Sell |
6,656
-464
| -7% | -$49.8K | 0.02% | 200 |
|
|
2025
Q1 | $718K | Sell |
7,120
-707
| -9% | -$71.3K | 0.02% | 183 |
|
|
2024
Q4 | $699K | Buy |
7,827
+126
| +2% | +$11.3K | 0.02% | 181 |
|
|
2024
Q3 | $645K | Buy |
7,701
+534
| +7% | +$44.7K | 0.02% | 203 |
|
|
2024
Q2 | $552K | Buy |
7,167
+17
| +0.2% | +$1.31K | 0.02% | 213 |
|
|
2024
Q1 | $490K | Sell |
7,150
-1,490
| -17% | -$102K | 0.02% | 219 |
|
|
2023
Q4 | $499K | Sell |
8,640
-2,343
| -21% | -$135K | 0.02% | 206 |
|
|
2023
Q3 | $580K | Sell |
10,983
-51
| -0.5% | -$2.69K | 0.02% | 192 |
|
|
2023
Q2 | $597K | Buy |
11,034
+371
| +3% | +$20.1K | 0.02% | 193 |
|
|
2023
Q1 | $533K | Buy |
10,663
+458
| +4% | +$22.9K | 0.02% | 201 |
|
|
2022
Q4 | $472K | Buy |
10,205
+904
| +10% | +$41.8K | 0.02% | 207 |
|
|
2022
Q3 | $360K | Buy |
9,301
+2,165
| +30% | +$83.8K | 0.02% | 208 |
|
|
2022
Q2 | $266K | Buy |
7,136
+2,472
| +53% | +$92.1K | 0.01% | 240 |
|
|
2022
Q1 | $207K | Sell |
4,664
-540
| -10% | -$24K | 0.01% | 242 |
|
|
2021
Q4 | $221K | Buy |
+5,204
| New | +$221K | 0.01% | 238 |
|